Press Archive
- Charles Francis: Weakening eye surgery laws places WV patients in jeopardy
- Mark D. Mayle, MD - 2022 Secretariat Award Recipients
- Dr. Larry Schwab recognized with 2020 International Blindness Prevention Award
- Wow Moment with Joseph A. LoCasio | Bio-Tissue | #WowWednesdays
- WVU Today | Moore, Oppe named recipients of Heebink award for Distinguished Service
- Cornea Transplant Restores Young Boy’s Sight After Fishing Accident
- Keep your eyes healthy and safe in the workplace
- Glaucoma Awareness Month
- Ophthalmologists Say 90 Percent of Work-Related Eye Injuries Can be Avoided by Wearing Eye Protection
- Five Tips to Avoid Toy-Related Eye Injuries
- Details
We thank Dr Lanza for his comments on our article in which we described the use of optical coherence tomography (OCT) to accurately measure corneal refractive power change after laser refractive surgery. As Dr Lanza notes, it has previously been shown that using automated or simulated keratometry, there is an underestimation of corneal power change using these keratometric techniques after myopic laser refractive surgery with the error increasing as the myopic correction increased.1–3 In the hyperopic population, the error was more variable depending on the amount of correction and duration of follow-up.
- Details
A 74-year-old man presented with a limbal mass (Fig 1A), found by incisional biopsy to be full-thickness conjunctival intraepithelial neoplasia (squamous cell carcinoma in situ) (Fig 1B, arrow). No significant inflammation was present at this stage. Despite 3 months of topical interferon α-2b therapy, the lesion enlarged (Fig 1C). The mass was surgically excised, and histopathology revealed progression to invasive squamous cell carcinoma with marked pleomorphism, numerous mitotic figures (Fig 1D, arrow), foreign body giant cells (Fig 1D, asterisk), and dyskeratosis.
- Details
I read with interest the article by McNabb et al1 regarding the measurement of corneal power in eyes that have undergone refractive surgery. One of the study's limitations was that myopic and hyperopic eyes were analyzed in a single group. It is known that after refractive surgery there is an overestimation of the corneal power in the eyes that had surgery for myopia,2,3 and there is an underestimation of the power of the cornea in eyes that had surgery for hyperopia.4 Evaluating the overall differences in corneal power for both refractive defects may introduce bias in assessing the accuracy of the variations before and after surgery.
- Details
To review the existing medical literature on the role of oral antibiotics in the management of ocular surface disease (OSD) that arises from disorders of the meibomian glands and to assess the efficacy of oral antibiotics in the management of this common ocular disease.
Read more: Oral Antibiotics for Meibomian Gland-Related Ocular Surface Disease
- Details
This correspondence concerns the results of a clinical trial for the United States Food and Drug Administration device exemption registration for the Tecnis toric intraocular lens.1 The goals of cataract surgery are varied,2 but are predominantly to provide best possible visual acuity targeted nowadays to aim for spectacle independence and this article gives us more evidence to support our choices.
- Details
I agree with the author about the need for more basic research on amblyopia; in fact, it is the subject of the concluding paragraph of my editorial. However, my task was to comment on the Pediatric Eye Disease Investigator Group (PEDIG) study of levodopa and its lack of utility in amblyopia treatment. I take it the author agrees with my comments, although the letter does not reflect this.